Associations between gene expression profiles of invasive breast cancer and Breast Imaging Reporting and Data System MRI lexicon.
10.4174/astr.2017.93.1.18
- Author:
Ga Ram KIM
1
;
You Jin KU
;
Soon Gu CHO
;
Sei Joong KIM
;
Byung Soh MIN
Author Information
1. Department of Radiology, Inha University Hospital, Inha University School of Medicine, Incheon, Korea.
- Publication Type:Original Article
- Keywords:
Breast neoplasms;
Magnetic resonance imaging;
Gene expression profiling
- From:Annals of Surgical Treatment and Research
2017;93(1):18-26
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: To evaluate whether the Breast Imaging Reporting and Data System (BI-RADS) MRI lexicon could reflect the genomic information of breast cancers and to suggest intuitive imaging features as biomarkers. METHODS: Matched breast MRI data from The Cancer Imaging Archive and gene expression profile from The Cancer Genome Atlas of 70 invasive breast cancers were analyzed. Magnetic resonance images were reviewed according to the BI-RADS MRI lexicon of mass morphology. The cancers were divided into 2 groups of gene clustering by gene set enrichment an alysis. Clinicopathologic and imaging characteristics were compared between the 2 groups. RESULTS: The luminal subtype was predominant in the group 1 gene set and the triple-negative subtype was predominant in the group 2 gene set (55 of 56, 98.2% vs. 9 of 14, 64.3%). Internal enhancement descriptors were different between the 2 groups; heterogeneity was most frequent in group 1 (27 of 56, 48.2%) and rim enhancement was dominant in group 2 (10 of 14, 71.4%). In group 1, the gene sets related to mammary gland development were overexpressed whereas the gene sets related to mitotic cell division were overexpressed in group 2. CONCLUSION: We identified intuitive imaging features of breast MRI associated with distinct gene expression profiles using the standard imaging variables of BI-RADS. The internal enhancement pattern on MRI might reflect specific gene expression profiles of breast cancers, which can be recognized by visual distinction.
